Study guide

12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

Veterinary Technician Specialist in Emergency and Critical Care VTS ECC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment

1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions

2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR

2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance

3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders

4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation

4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics

5 Chapter 5: Gastrointestinal & Hepatic Emergencies

5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies

6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions

6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions

7 Chapter 7: Renal & Urinary Emergencies

7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation

8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS

8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia

9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies

9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles

10 Chapter 10: Neurological Emergencies

10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization

11 Chapter 11: Endocrine & Metabolic Crises

11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

12 Chapter 12: Reproductive & Musculoskeletal Emergencies

12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20

13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist

12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

Key Takeaways Explain This Topic AI

Rhabdomyolysis and Crush Injury Syndrome result from mechanical compression and ischemia-reperfusion injury causing massive skeletal myocyte lysis, releasing lethal quantities of potassium, phosphorus, lactic acid, creatine kinase (CK >10,000-100,000 U/L), and myoglobin into the systemic circulation.

Diagnostic differentiation of red/brown urine relies on urine centrifugation and serum inspection: a red pellet with clear supernatant confirms hematuria; a red supernatant with clear serum confirms myoglobinuria; a red supernatant with pink/red serum indicates hemoglobinuria (confirmed via 80% ammonium sulfate precipitation test).

Myoglobin induces acute tubular necrosis (ATN) through renal vasoconstriction, tubular cast obstruction with Tamm-Horsfall proteins in acidic urine (pH <5.6), and direct heme iron oxidant cytotoxicity; prevention requires aggressive high-volume balanced crystalloid diuresis (2-3x maintenance) and urinary alkalinization.

The Lethal Triad of Trauma comprises Hypothermia (<95°F/35°C), Severe Acidosis (pH <7.20), and Trauma-Induced Coagulopathy (TIC); Damage Control Surgery (DCS) halts this lethal spiral by utilizing abbreviated surgery (<60 min) strictly for hemorrhage and contamination control, deferring definitive reconstruction until ICU physiological stabilization.

Damage Control Resuscitation (DCR) protocols emphasize Permissive Hypotension (targeting MAP 50-60 mmHg / SBP 80-90 mmHg until surgical hemostasis), early Tranexamic Acid (TXA 10-20 mg/kg IV within 3 hours of trauma), and balanced Massive Transfusion Protocols (1:1:1 ratio of pRBCs, FFP, and Platelets).

Last updated: August 2026

Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

VTS Critical Concept: In massive polytrauma and crush injuries, patient survival is dictated not by immediate anatomic reconstruction, but by proactive physiologic resuscitation. Severe rhabdomyolysis releases lethal intracellular toxins (potassium, myoglobin) capable of inducing fatal cardiac arrest and anuric acute kidney injury. Concurrently, severe polytrauma triggers the Lethal Triad of Trauma (Hypothermia, Acidosis, and Coagulopathy) , requiring modern Damage Control Resuscitation (DCR) strategies: permissive hypotension, early antifibrinolytic therapy (TXA), and balanced 1:1:1 component transfusion.

1. Rhabdomyolysis & Crush Injury Syndrome: Pathophysiology

Rhabdomyolysis is the rapid dissolution and necrosis of skeletal muscle fibers resulting in the release of intracellular myocyte contents into the systemic circulation. It occurs following massive blunt trauma, vehicular crush injury, entrapment/prolonged recumbency, severe exertional heatstroke, status epilepticus, or ischemic-reperfusion injury following arterial thromboembolism. [ Pathophysiology of Crush Injury & Rhabdomyolysis ]

  • │
  • Direct Mechanical Compression + Ischemia-Reperfusion Insult
  • │
  • ▼
  • Depletion of Intracellular ATP & Failure of Na+/K+ & Ca2+ ATPases
  • │
  • ▼
  • Massive Influx of Extracellular Sodium (Na+) and Ionized Calcium (Ca2+)
  • │
  • ▼
  • Activation of Intracellular Proteases, Phospholipases & Endonucleases
  • │
  • ▼
  • Complete Sarcolemmal Rupture & Massive Release of Myocyte Contents
  • │
  • ┌─────────────────┼────────────────────────┐
  • ▼ ▼ ▼
  • [ Hyperkalemia ] [ Hyperphosphatemia ] [ Myoglobin & CK Surge ]
  • K+ > 6.5-8.0 mEq/L • Drives acute hypocalcemia • CK > 10,000-100,000 U/L
  • Fatal dysrhythmias • Metastatic calcification • Pigment Nephropathy / AKI
  • Sine wave / arrest • Lactic acidosis & shock
  • Systemic Toxic Cascades

Released Intracellular Constituent Pathophysiological Cascade Clinical & Diagnostic Manifestations

Potassium ( K + K^+ K + ) Massive release of intracellular K + K^+ K + into the extracellular space Life-Threatening Hyperkalemia ( > 6.5 − 8.0 mmol/L >6.5-8.0\text{ mmol/L} > 6.5 − 8.0 mmol/L ): Peaked/tented T waves, loss of P waves, PR interval prolongation, wide bizarre QRS complexes, sine waves, and asystolic cardiac arrest

Phosphorus ( P O 4 3 − PO_4^{3-} P O 4 3 − ​ ) Release of intracellular inorganic phosphate Hyperphosphatemia & Secondary Hypocalcemia: Calcium-phosphate precipitation in soft tissues and myocardium, precipitating acute hypocalcemic tetany and myocardial dysfunction

Creatine Kinase (CK) Lysis of cytoplasmic skeletal muscle enzymes Diagnostic marker of muscle necrosis: Serum CK surges from normal ( < 200 − 300 U/L <200-300\text{ U/L} < 200 − 300 U/L ) to > 10 , 000 − 100 , 000 + U/L >10,000-100,000+\text{ U/L} > 10 , 000 − 100 , 000 + U/L within 12 − 24 hours 12-24\text{ hours} 12 − 24 hours

Myoglobin (17.8 kDa) Small, oxygen-binding heme protein freely filtered across the renal glomerulus Pigment Nephropathy & Anuric AKI: Dark red/brown/tea-colored urine, tubular obstruction by pigment casts, acute tubular necrosis, and severe azotemia

Lactic Acid & Purines Severe local anaerobic metabolism and nucleic acid degradation High anion gap metabolic acidosis ( p H < 7.15 pH < 7.15 p H < 7.15 ) , hyperuricemia, and worsening systemic vasodilation

2. Differential Diagnosis of Pigmenturia: Myoglobinuria vs. Hemoglobinuria vs. Hematuria

When a trauma patient presents with red, dark brown, or 'port wine' colored urine, the veterinary critical care technician must immediately execute a systematic 3-step diagnostic laboratory differentiation: [ Diagnostic Differentiation of Red/Brown Urine ]

  • │
  • ▼
  • STEP 1: CENTRIFUGE URINE SAMPLE (1,500 rpm for 5 min)
  • │
  • ┌────────────────┴────────────────────────┐
  • ▼ ▼
  • [ Red Pellet at Bottom + Clear Supernatant ] [ Supernatant Remains Dark Red/Brown ]
  • DIAGNOSIS: HEMATURIA • DIAGNOSIS: PIGMENTURIA (Heme Present)
  • Intact Red Blood Cells in Urine (Proceed to Step 2: Blood Centrifugation)
  • Hemorrhage from urinary tract / trauma
  • │
  • ▼
  • STEP 2: CENTRIFUGE ANTICOAGULATED BLOOD / HEMATOCRIT TUBE
  • │
  • ┌────────────────┴────────────────────────┐
  • ▼ ▼
  • [ Plasma / Serum is WATER-CLEAR ] [ Plasma / Serum is PINK / RED (Hemolyzed) ]
  • DIAGNOSIS: MYOGLOBINURIA • DIAGNOSIS: HEMOGLOBINURIA
  • Myoglobin is small (17.8 kDa), • Hemoglobin is large (64.5 kDa) and binds
  • unbound to plasma proteins, and cleared avidly to Haptoglobin. Once saturated,

rapidly by kidneys into urine. free hemoglobin accumulates in plasma.

  • │
  • ▼
  • STEP 3: 80% AMMONIUM SULFATE PRECIPITATION TEST (Confirmatory)
  • Add (NH4)2SO4 to urine: Hemoglobin precipitates out; Myoglobin remains in solution
  • Comparative Laboratory Characteristics

Parameter Hematuria Hemoglobinuria Myoglobinuria

Urine Color Before Centrifugation Red to cloudy pink Translucent dark red / port wine Translucent dark brown / cola-colored

Urine Supernatant Post-Centrifugation Clear / Yellow (RBCs form red pellet) Red / Burgundy (Pigment remains dissolved) Dark Brown / Red (Pigment remains dissolved)

Urine Dipstick (Occult Blood Pad) Positive (intact RBCs lyse on pad) Positive (detects heme moiety) Positive (detects heme moiety)

Urine Sediment Microscopy Numerous intact RBCs ( > 5 RBCs/hpf >5\text{ RBCs/hpf} > 5 RBCs/hpf ) Absent to rare RBCs Absent to rare RBCs; granular / brown casts

Plasma / Serum Appearance Normal / Clear Pink to Bright Red (Hemolyzed) Completely Clear / Water-like

Serum Creatine Kinase (CK) Normal to mildly elevated Normal to mildly elevated Markedly Elevated ( > 10 , 000 − 100 , 000 U/L >10,000-100,000\text{ U/L} > 10 , 000 − 100 , 000 U/L )

Serum Haptoglobin Normal Severely Depleted / Zero Normal

  • 3. Prevention & Management of Myoglobinuric Acute Kidney Injury (AKI)
  • Pathogenesis of Myoglobin Nephrotoxicity

Myoglobin induces Acute Tubular Necrosis (ATN) through three synergistic pathophysiological mechanisms:

Renal Medullary Vasoconstriction: Free heme proteins scavenge endothelial nitric oxide (NO) , causing severe intrarenal vasoconstriction, renal medullary ischemia, and a drastic decline in Glomerular Filtration Rate (GFR).

Intratubular Cast Precipitation: Under acidic urinary conditions ( p H < 5.6 pH < 5.6 p H < 5.6 ), myoglobin dissociates into ferrihemate (hematin) , which aggregates and precipitates with Tamm-Horsfall mucoprotein in the distal convoluted tubules, forming dense, occlusive tubular casts.

Direct Oxidant Cytotoxicity: The iron ( F e 2 + / F e 3 + Fe^{2+}/Fe^{3+} F e 2 + / F e 3 + ) in the heme ring catalyzes the generation of toxic hydroxyl free radicals via the Fenton reaction , inducing lipid peroxidation of proximal tubular cell membranes and cell death.

Nephroprotective Fluid Diuresis Protocols

Aggressive Balanced Crystalloid Resuscitation: Initiate high-volume intravenous diuresis using balanced isotonic crystalloids (Plasmalyte-A, Normosol-R, or LRS) at 2 − 3 × maintenance 2-3\times\text{ maintenance} 2 − 3 × maintenance ( 6 − 10 mL/kg/hr 6-10\text{ mL/kg/hr} 6 − 10 mL/kg/hr ) initially to expand intravascular volume, restore renal perfusion, and flush obstructing casts from the renal tubules.

Target Urine Output (UOP): Place a closed indwelling Foley catheter to monitor hourly urine output. The mandatory therapeutic endpoint is UOP > 2.0 − 3.0 mL/kg/hr \text{UOP} > 2.0-3.0\text{ mL/kg/hr} UOP > 2.0 − 3.0 mL/kg/hr .

Urinary Alkalinization Considerations: In severe myoglobinuria, administer Sodium Bicarbonate ( 1 − 2 mEq/kg 1-2\text{ mEq/kg} 1 − 2 mEq/kg slow IV over 4 − 6 hours 4-6\text{ hours} 4 − 6 hours ) or add to IV fluids to maintain urine p H > 6.5 − 7.0 pH > 6.5-7.0 p H > 6.5 − 7.0 . Alkalinization prevents the dissociation of myoglobin into toxic ferrihemate and inhibits cast precipitation. (Caution: Avoid over-alkalinization, which can worsen hypocalcemia and cause metabolic alkalosis).

Emergency Treatment of Severe Hyperkalemia ( K + > 7.0 mmol/L K^+ > 7.0\text{ mmol/L} K + > 7.0 mmol/L ):

Myocardial Protection: 10% Calcium Gluconate ( 0.5 − 1.0 mL/kg 0.5-1.0\text{ mL/kg} 0.5 − 1.0 mL/kg slow IV over 10 min 10\text{ min} 10 min ) under continuous ECG monitoring to restore normal cardiac membrane threshold potentials (does not lower serum potassium).

Intracellular Potassium Shifting: Regular Insulin ( 0.25 − 0.5 Units/kg 0.25-0.5\text{ Units/kg} 0.25 − 0.5 Units/kg IV) accompanied immediately by a 50% Dextrose bolus ( 1 − 2 g per Unit of insulin 1-2\text{ g per Unit of insulin} 1 − 2 g per Unit of insulin diluted 1 : 1 1:1 1 : 1 with saline) , followed by a continuous 2.5 − 5.0 % 2.5-5.0\% 2.5 − 5.0% dextrose infusion to prevent severe hypoglycemia.

Loading diagram... The Lethal Triad of Trauma and Damage Control Resuscitation

4. Polytrauma & The Lethal Triad of Trauma

In severe polytrauma, mortality is driven by a self-propagating pathophysiological vortex known as the Lethal Triad of Trauma :

Hypothermia (Core Temperature < 95.0 ∘ F / 35.0 ∘ C <95.0^\circ\text{F}\ /\ 35.0^\circ\text{C} < 95. 0 ∘ F / 35. 0 ∘ C ):

Caused by shock-induced hypoperfusion, exposure, and massive infusion of room-temperature fluids.

Directly impairs the enzymatic kinetics of the coagulation cascade; clotting factor activity drops by 10 % 10\% 10% for every 1.0 ∘ C 1.0^\circ\text{C} 1. 0 ∘ C drop in body temperature .

Inhibits platelet activation, adhesion, and thromboxane A 2 A_2 A 2 ​ synthesis.

Severe Metabolic Acidosis ( p H < 7.20 pH < 7.20 p H < 7.20 , Base Deficit > − 10 mmol/L > -10\text{ mmol/L} > − 10 mmol/L , Blood Lactate > 5.0 mmol/L >5.0\text{ mmol/L} > 5.0 mmol/L ):

Results from profound systemic tissue hypoperfusion, cellular hypoxia, and anaerobic glycolysis.

Severely suppresses coagulation protease assembly: the enzymatic activity of the Factor VIIa/Tissue Factor complex decreases by 90 % 90\% 90% at p H 7.0 pH 7.0 p H 7.0 .

Depresses myocardial contractility and induces refractory peripheral vasodilation.

Trauma-Induced Coagulopathy (TIC):

An acute endogenous impairment of hemostasis triggered within minutes of trauma by massive tissue injury, endothelial damage, activated protein C upregulation, and hyperfibrinolysis.

Severely exacerbated iatrogenically by crystalloid hemodilution (washing out clotting factors and platelets) and hypothermia.

5. Damage Control Resuscitation (DCR) & Damage Control Surgery (DCS)

Traditional resuscitation paradigms emphasizing massive crystalloid boluses ( 60 − 90 mL/kg 60-90\text{ mL/kg} 60 − 90 mL/kg ) and immediate definitive 4-hour orthopedic/cavitary reconstructions have been replaced by Damage Control Resuscitation (DCR) .

  • Modern Damage Control Pillars [ The Four Pillars of Damage Control Resuscitation ]
  • │
  • ┌────────────────┼────────────────────────┬────────────────────────┐
  • ▼ ▼ ▼ ▼
  • [ Permissive [ Early TXA [ Balanced MTP [ Damage Control
  • Hypotension ] Antifibrinolytic ] 1:1:1 Ratio ] Surgery (DCS) ]
  • Target MAP • 10-20 mg/kg IV slow • 1 pRBC : 1 FFP : • Abbreviated surgery
  • 50-60 mmHg over 15-20 min 1 Platelet unit (< 60 minutes)
  • Target SBP • MUST give within • Prevents dilutional • Stop active bleeding
  • 80-90 mmHg 3 HOURS of trauma coagulopathy and contamination
  • Avoids 'Popping • Blocks plasminogen • Serial ionized Ca2+ • Defer definitive
  • the Clot' activation monitoring repair to ICU phase
  • Detailed Resuscitation Principles

Permissive Hypotension (Hypotensive Resuscitation):

Principle: Restricting the rate and volume of intravenous crystalloids prior to surgical hemostasis.

Target Endpoints: Maintain a Mean Arterial Pressure (MAP) of 50 − 60 mmHg 50-60\text{ mmHg} 50 − 60 mmHg or a Systolic Blood Pressure (SBP) of 80 − 90 mmHg 80-90\text{ mmHg} 80 − 90 mmHg (palpable femoral pulse, clear mentation).

Physiological Rationale: Delivering large crystalloid boluses elevates intravascular hydrostatic pressure and dilutes coagulation factors, which dislodges newly formed hemostatic clots ('popping the clot') and accelerates fatal cavitary hemorrhage.

ABSOLUTE CONTRAINDICATION: Traumatic Brain Injury (TBI) . In patients with concurrent TBI, permissive hypotension is strictly contraindicated; maintaining cerebral perfusion pressure requires keeping M A P > 80 mmHg MAP > 80\text{ mmHg} M A P > 80 mmHg ( S B P > 100 − 110 mmHg SBP > 100-110\text{ mmHg} SBP > 100 − 110 mmHg ) .

Early Tranexamic Acid (TXA) Administration:

Mechanism: TXA is a synthetic lysine analog that competitively binds to plasminogen, preventing its activation to plasmin and halting hyperfibrinolytic clot breakdown.

Dosage & Timing: Administer 10 − 20 mg/kg 10-20\text{ mg/kg} 10 − 20 mg/kg IV slow over 15 − 20 minutes 15-20\text{ minutes} 15 − 20 minutes . Mandatory Timing Window: TXA must be administered within 3 hours of trauma onset . Administration > 3 hours >3\text{ hours} > 3 hours post-injury paradoxically increases mortality by exacerbating microvascular thrombosis and inflammatory tissue injury.

Massive Transfusion Protocol (MTP) & Balanced Blood Ratios:

Indicated in catastrophic trauma hemorrhage (defined as loss of > 50 % >50\% > 50% total blood volume within 3 hours 3\text{ hours} 3 hours , or > 100 % >100\% > 100% blood volume within 24 hours 24\text{ hours} 24 hours ).

1:1:1 Balanced Ratio: Deliver equal ratios of Packed Red Blood Cells (pRBCs) , Fresh Frozen Plasma (FFP) , and Platelet Concentrates / Cryoprecipitate (e.g., 1 unit pRBC : 1 unit FFP : 1 unit Platelets 1\text{ unit pRBC} : 1\text{ unit FFP} : 1\text{ unit Platelets} 1 unit pRBC : 1 unit FFP : 1 unit Platelets ). Balanced component therapy prevents dilutional coagulopathy, severe thrombocytopenia, and hypofibrinogenemia.

Citrate Toxicity & Ionized Calcium: Blood products are preserved with citrate, which binds circulating ionized calcium. During massive transfusion, monitor i C a 2 + iCa^{2+} i C a 2 + every 30-60 minutes; administer 10 % 10\% 10% Calcium Gluconate ( 0.5 mL/kg 0.5\text{ mL/kg} 0.5 mL/kg slow IV) if i C a 2 + < 1.0 mmol/L iCa^{2+} < 1.0\text{ mmol/L} i C a 2 + < 1.0 mmol/L to prevent myocardial depression and worsening coagulopathy.

Damage Control Surgery (DCS):

Abbreviated Surgical Time ( < 60 minutes <60\text{ minutes} < 60 minutes ): Rapid laparotomy/thoracotomy strictly limited to controlling active surgical hemorrhage (direct clamping, packing, vascular shunting) and controlling gastrointestinal contamination (rapid stapling/ligation without resection).

Temporary Abdominal Closure (TAC): Abdomen is packed and closed temporarily using vacuum-assisted closure (open peritoneal drainage).

ICU Resuscitation Phase: Patient is transferred immediately to the ICU for aggressive active rewarming, correction of severe metabolic acidosis, reversal of coagulopathy with FFP and platelets, and optimization of oxygen delivery.

Definitive Reconstruction: The patient returns to the OR 24 − 48 hours 24-48\text{ hours} 24 − 48 hours later for definitive organ reconstruction and fracture fixation once physiological homeostasis has been fully restored.